期刊文献+

ICU获得性衰弱危险因素研究进展 被引量:3

Research Progress in Risk Factors for ICU-Acquired Weakness
下载PDF
导出
摘要 ICU获得性衰弱(ICU-AW)的危险因素包括患者个体因素、临床辅助治疗、各类生化代谢指标、药物治疗情况、相关并发症及医护人员对ICU-AW的认识情况等。早期发现、早期进行治疗和护理干预是治疗ICU-AW的关键。今后ICU-AW危险因素的研究应关注患者住院期间心理社会状态,并提高医护人员对该病的知信行,可尽早预防该病的发生。 The risk factors for ICU-acquired weakness(AW)include individual factors,clinical adjuvant therapy,various biochemical metabolic indexes,drug treatment,related complications,and understanding of medical staff on ICU-AW.Early detection,early treatment and nursing intervention are the key to the treatment of ICU-AW.In the future,studies regarding ICU-AW risk factors should focus on patients’psychosocial status during hospitalization,and the knowledge,belief and behavior of medical staff should be improved to prevent the occurrence of ICU-AW as soon as possible.
作者 刘丽萍 李冬英 李瑛 朱建庭 胡燕 肖伽 谢湘梅 LIU Li-ping;LI Dong-ying;LI Ying;ZHU Jian-ting;HU Yan;XIAO Jia;XIE Xiang-mei(Department of Critical Medicine,the Second Affiliated Hospital;College of Nursing;Department of Respiratory and Critical Care Medicine,the Second Affiliated Hospital,Nanchang University,Nanchang 330006,China)
出处 《南昌大学学报(医学版)》 2021年第5期87-92,共6页 Journal of Nanchang University:Medical Sciences
基金 江西省科技厅重点研发计划项目(20202BBGL73043)。
关键词 获得性衰弱 ICU 危险因素 重症 心理社会状态 知信行 acquired weakness ICU risk factors severe psychosocial state knowledge,belief and behavior
  • 相关文献

参考文献16

二级参考文献144

  • 1王书林.应用舒芬太尼联合丙泊酚为ICU机械通气患者进行镇痛镇静的效果观察[J].当代医药论丛,2014,12(13):171-172. 被引量:8
  • 2安友仲,邱海波,黄青青,康焰,管向东.中国重症加强治疗病房患者镇痛和镇静治疗指导意见(2006)[J].中华外科杂志,2006,44(17):1158-1166. 被引量:243
  • 3Warr J,Thiboutot Z, Rose L, et al. Current therapeutic uses, pharmacology, and clinical considerations of neuromuscular blocking agentsfor critically ill adults[ J ] Ann Pharmacother,2011,45(9):1116-1126.
  • 4Merriman HM. The techniques used to sedate ventilated pa- tients. Asurvey of methods used in 34 ICUs in Great Britain [ J]. Intensive Care Med, 1981,7(5 ) :217-224.
  • 5Arroliga A, Frutos-Vivar F, Hall J, et al. International Mechani- cal Ventilation Study Group:Use of sedatives and neuromuscu- lar blockers in a cohort of patients receiving mechanical ventila- tion[J]. Chest,2005,128(2) :496-506.
  • 6Fagerland MJ, Erikkson LI. Current concepts in neuromuscular transmission [ J ]. Br J Anaesth ,2009,103 ( 1 ) : 108-114.
  • 7Jonsson Fagerlund M,Dabrowski M,Eriksson LI. Pharmacological characteristics of the inhibition of nondepolarizing neuromuscular blocking agents at human adult muscle nicotinic acetylcholine re- ceptor[J]. Anesthesiology,2009,110(6) :1244-1252.
  • 8McManus MC. Neuromuscular blockers in surgery and intensive care,part [J]. Am J Health Syst Pharm,2001,58(23) :2287- 2299.
  • 9Miller R. Miller' s Anesthesia [ M ]. 7th Edition. Orlando, FL: Churchill Livingstone, 2009 : 1-3312.
  • 10Smeulers NJ, Wierda JM, van den Broek L, et al. Effects of hy- pothermic cardiopulmonary bypass on the pharmacodynamics and pharmacokinetics of rocuronium [ J ]. J Cardiothorac Vasc Anesth, 1995,9 ( 6 ) : 700-705.

共引文献466

同被引文献40

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部